Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season

Yearly administration of influenza vaccine with recommendations can help control seasonal influenza epidemics in adults aged ≥60 years. Here, we describe the results of a prospective study observing the immunogenicity and persistence of induced immunity of a trivalent inactivated split-virion influe...

Full description

Bibliographic Details
Main Authors: Yuting Liao, Yan Jin, Hangjie Zhang, Juan Yang, Jian Fu, Huakun Lv
Format: Article
Language:English
Published: Taylor & Francis Group 2022-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2022.2071061
_version_ 1797673212899753984
author Yuting Liao
Yan Jin
Hangjie Zhang
Juan Yang
Jian Fu
Huakun Lv
author_facet Yuting Liao
Yan Jin
Hangjie Zhang
Juan Yang
Jian Fu
Huakun Lv
author_sort Yuting Liao
collection DOAJ
description Yearly administration of influenza vaccine with recommendations can help control seasonal influenza epidemics in adults aged ≥60 years. Here, we describe the results of a prospective study observing the immunogenicity and persistence of induced immunity of a trivalent inactivated split-virion influenza vaccine (TIV) in adults aged ≥60 years during the 2018–2019 season in Taizhou City, Zhejiang Province in China. A total of 422 participants completed the study period. Vaccinated participants (284) received a single dose of TIV, but unvaccinated participants (138) didn’t receive any vaccine. Study participants vaccinated with TIV had significantly higher GMTs of Hemagglutination Inhibition (HI) antibodies against AH1N1, AH2N3, and B/Victoria strains (all p < .0001) at day 30 post-vaccination compared with unvaccinated participants, but the antibody response to the B/Victoria strain was the weakest. Rates of seroprotection and seroconversion were generally higher in the TIV-vaccinated group. At day 180 post-vaccination, the seroconversion rates (95%CI) in the vaccinated group were 99.6% (99.0%–100.3%), 97.9% (96.2%–99.6%), and 68.3% (62.9%–73.8%) for antibodies against three influenza strains, respectively; these rates were significantly different compared with unvaccinated group only for strains AH3N2 and B/Victoria (p = .002 and p < .0001, respectively). These results confirm that in adults aged ≥60 years, a single dose of TIV can induce a protective immune response against influenza, but the protective HI antibody levels induced against strain B/Victoria do not persist through 6 months.
first_indexed 2024-03-11T21:41:13Z
format Article
id doaj.art-ee3b08eddc394d308ea0f271fe174c63
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T21:41:13Z
publishDate 2022-11-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-ee3b08eddc394d308ea0f271fe174c632023-09-26T13:19:06ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-11-0118510.1080/21645515.2022.20710612071061Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 seasonYuting Liao0Yan Jin1Hangjie Zhang2Juan Yang3Jian Fu4Huakun Lv5Xiamen UniversityTaizhou Municipal Center for Disease Control and PreventionZhejiang Provincial Center for Disease Control and PreventionXiamen UniversityZhejiang Provincial Center for Disease Control and PreventionZhejiang Provincial Center for Disease Control and PreventionYearly administration of influenza vaccine with recommendations can help control seasonal influenza epidemics in adults aged ≥60 years. Here, we describe the results of a prospective study observing the immunogenicity and persistence of induced immunity of a trivalent inactivated split-virion influenza vaccine (TIV) in adults aged ≥60 years during the 2018–2019 season in Taizhou City, Zhejiang Province in China. A total of 422 participants completed the study period. Vaccinated participants (284) received a single dose of TIV, but unvaccinated participants (138) didn’t receive any vaccine. Study participants vaccinated with TIV had significantly higher GMTs of Hemagglutination Inhibition (HI) antibodies against AH1N1, AH2N3, and B/Victoria strains (all p < .0001) at day 30 post-vaccination compared with unvaccinated participants, but the antibody response to the B/Victoria strain was the weakest. Rates of seroprotection and seroconversion were generally higher in the TIV-vaccinated group. At day 180 post-vaccination, the seroconversion rates (95%CI) in the vaccinated group were 99.6% (99.0%–100.3%), 97.9% (96.2%–99.6%), and 68.3% (62.9%–73.8%) for antibodies against three influenza strains, respectively; these rates were significantly different compared with unvaccinated group only for strains AH3N2 and B/Victoria (p = .002 and p < .0001, respectively). These results confirm that in adults aged ≥60 years, a single dose of TIV can induce a protective immune response against influenza, but the protective HI antibody levels induced against strain B/Victoria do not persist through 6 months.http://dx.doi.org/10.1080/21645515.2022.2071061seasonal influenzavaccinetrivalentimmunogenicitypersistence of immunityelderly
spellingShingle Yuting Liao
Yan Jin
Hangjie Zhang
Juan Yang
Jian Fu
Huakun Lv
Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season
Human Vaccines & Immunotherapeutics
seasonal influenza
vaccine
trivalent
immunogenicity
persistence of immunity
elderly
title Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season
title_full Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season
title_fullStr Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season
title_full_unstemmed Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season
title_short Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season
title_sort immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in taizhou city zhejiang province china during the 2018 2019 season
topic seasonal influenza
vaccine
trivalent
immunogenicity
persistence of immunity
elderly
url http://dx.doi.org/10.1080/21645515.2022.2071061
work_keys_str_mv AT yutingliao immunogenicityofatrivalentinfluenzavaccineandpersistenceofinducedimmunityinadultsaged60yearsintaizhoucityzhejiangprovincechinaduringthe20182019season
AT yanjin immunogenicityofatrivalentinfluenzavaccineandpersistenceofinducedimmunityinadultsaged60yearsintaizhoucityzhejiangprovincechinaduringthe20182019season
AT hangjiezhang immunogenicityofatrivalentinfluenzavaccineandpersistenceofinducedimmunityinadultsaged60yearsintaizhoucityzhejiangprovincechinaduringthe20182019season
AT juanyang immunogenicityofatrivalentinfluenzavaccineandpersistenceofinducedimmunityinadultsaged60yearsintaizhoucityzhejiangprovincechinaduringthe20182019season
AT jianfu immunogenicityofatrivalentinfluenzavaccineandpersistenceofinducedimmunityinadultsaged60yearsintaizhoucityzhejiangprovincechinaduringthe20182019season
AT huakunlv immunogenicityofatrivalentinfluenzavaccineandpersistenceofinducedimmunityinadultsaged60yearsintaizhoucityzhejiangprovincechinaduringthe20182019season